Dolby Laboratories, Inc. vs McKesson Corporation — how do they compare? Dolby Laboratories, Inc. trades at $60.91 (market cap $5.75B), while McKesson Corporation trades at $895.01 (market cap $105.14B). The key difference: McKesson Corporation is far larger — about 18.3× Dolby Laboratories, Inc.'s market cap, and Dolby Laboratories, Inc. pays the higher dividend (2.35%). Which is the better fit depends on your goals.
| DLB | MCK | |
|---|---|---|
Market Cap | $5.75B | $105.14B |
Sector | Industrials | Health |
52-Week High | $75.62 | $995.69 |
52-Week Low | $48.51 | $659.01 |
Enterprise Value | $5.12B | $111.67B |
Dividend Yield | 2.35% | 0.42% |
Trailing returns across standard periods
Dolby Laboratories Inc develops audio and surround sound for cinema, broadcast, home audio systems, in-car entertainment systems, DVD players, games, televisions, and personal computers. The company generates three fourths of its revenue from licensing its technology to consumer electronics manufacturers around the world. The rest of revenue comes from equipment sales to professional producers and audio engineering services.
Read more on DLB →McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →